Alnylam Pharmaceuticals filed disclosures regarding its share holdings with the SEC on May 27, 2026.

The entities involved

• Alnylam Pharmaceuticals →

  biopharmaceutical company

  • AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
  • Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.Sun 17:03
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Applied Materials made disclosures regarding company filings on August 30, 2026.Aug 30
• LifeStance Health Group filed disclosures with the SEC regarding stock purchases on September 6, 2026.Sep 6
• OPAL Fuels filed a company disclosure with the SEC on September 2, 2026.Sep 2
• Cousins Properties filed disclosures regarding share purchases and dividends with the SEC.Sep 11
• Allient stock traded on NASDAQ and filed required disclosures with the SEC on August 18, 2026.Aug 18